GeneDx Holdings ROE 2020-2025 | WGS
Current and historical return on equity (ROE) values for GeneDx Holdings (WGS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| GeneDx Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.04B | $0.26B | -17.31% |
| 2024-12-31 | $-0.05B | $0.25B | -24.44% |
| 2024-09-30 | $-0.08B | $0.21B | -39.81% |
| 2024-06-30 | $-0.12B | $0.19B | -53.00% |
| 2024-03-31 | $-0.14B | $0.21B | -54.82% |
| 2023-12-31 | $-0.18B | $0.23B | -63.65% |
| 2023-09-30 | $-0.46B | $0.25B | -162.19% |
| 2023-06-30 | $-0.50B | $0.30B | -137.60% |
| 2023-03-31 | $-0.53B | $0.33B | -120.00% |
| 2022-12-31 | $-0.55B | $0.25B | -123.53% |
| 2022-09-30 | $-0.28B | $0.56B | -58.69% |
| 2022-06-30 | $-0.17B | $0.64B | -38.97% |
| 2022-03-31 | $-0.13B | $0.33B | -46.72% |
| 2021-12-31 | $-0.25B | $0.39B | -124.21% |
| 2021-06-30 | $-0.30B | $0.01B | -11800.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.308B | $0.305B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.913B | 25.22 |
| CVS Health (CVS) | United States | $77.267B | 9.60 |
| Elevance Health (ELV) | United States | $63.437B | 8.53 |
| Cencora (COR) | United States | $56.784B | 19.75 |
| DiDi Global (DIDIY) | China | $26.545B | 28.20 |
| Labcorp Holdings (LH) | United States | $21.098B | 17.11 |
| Natera (NTRA) | United States | $19.106B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.371B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.731B | 35.52 |
| CochLear (CHEOY) | Australia | $13.060B | 0.00 |
| ICON (ICLR) | Ireland | $13.042B | 12.12 |
| Solventum (SOLV) | United States | $12.616B | 13.35 |
| Revvity (RVTY) | United States | $11.331B | 19.50 |
| Viatris (VTRS) | United States | $10.845B | 3.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.965B | 0.00 |
| Avantor (AVTR) | United States | $8.872B | 12.89 |
| HealthEquity (HQY) | United States | $8.424B | 36.90 |
| Charles River Laboratories (CRL) | United States | $8.024B | 15.72 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.706B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.059B | 29.79 |
| BrightSpring Health Services (BTSG) | United States | $3.542B | 32.50 |
| Sotera Health (SHC) | United States | $3.225B | 18.32 |
| Surgery Partners (SGRY) | United States | $2.827B | 36.77 |
| Organon (OGN) | United States | $2.553B | 2.71 |
| Concentras Parent (CON) | United States | $2.534B | 14.64 |
| Alignment Healthcare (ALHC) | United States | $2.441B | 0.00 |
| Progyny (PGNY) | United States | $1.970B | 43.36 |
| GoodRx Holdings (GDRX) | United States | $1.757B | 35.14 |
| PACS (PACS) | United States | $1.750B | 0.00 |
| Premier (PINC) | United States | $1.738B | 13.19 |
| Ardent Health (ARDT) | United States | $1.503B | 6.41 |
| Teladoc Health (TDOC) | United States | $1.477B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.257B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.094B | 8.33 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.763B | 7.14 |
| CareDx (CDNA) | United States | $0.725B | 11.32 |
| Embecta (EMBC) | United States | $0.625B | 4.21 |
| Nutex Health (NUTX) | United States | $0.556B | 8.41 |
| So-Young (SY) | China | $0.541B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
| SBC Medicals (SBC) | United States | $0.516B | 0.00 |
| Omada Health (OMDA) | $0.495B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
| LifeMD (LFMD) | United States | $0.471B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.17 |
| Oncology Institute (TOI) | United States | $0.316B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.287B | 0.00 |
| Beauty Health (SKIN) | United States | $0.231B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Pheton Holdings (PTHL) | China | $0.148B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.109B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| KindlyMD (NAKA) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.051B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.016B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |